Aeterna Zentaris to Present at Upcoming Canaccord Genuity 35th Annual Global Growth Conference in Boston

QUÉBEC CITY, Aug. 4, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the Company's Chairman and CEO, David Dodd, will be presenting a corporate overview at the Canaccord Genuity 35^th Annual Global Growth Conference on Wednesday, August 12, 2015, at 11 am (Eastern), in the Melbourne Room of the Intercontinental Hotel in Boston.

A live audio and slide webcast of the presentation will be available via the Company's website at www.aezsinc.com in the "Newsroom" section, under "Events and Webcasts". A replay of the webcast will also be available on the Company's website for a period of 90 days.

About Aeterna Zentaris Inc.

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. For more information, visit www.aezsinc.com.

SOURCE Aeterna Zentaris Inc.

Paul Burroughs, Director of Communications, [phone] ext. 406, [email protected]